TNFSF10 and neoplasm: Interestingly, one of the unique aspects of TRAIL, as compared to the other proapoptotic ligands [19, 20], is that TRAIL has the ability to induce apoptosis preferentially in transformed cells, such as tumor or infected cells, while it would spare most normal cells [21].